- Home
- TMCI vs SIGA Comparison
TMCI vs SIGA Comparison
Compare TMCI & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMCI | SIGA |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 279.6M | 223.8M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TMCI | SIGA |
|---|---|---|
| Price | $4.34 | $3.04 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.77 | N/A |
| AVG Volume (30 Days) | 390.8K | ★ 823.3K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | ★ $212,690,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.18 | $224.81 |
| P/E Ratio | ★ N/A | $22.85 |
| Revenue Growth | ★ 1.59 | N/A |
| 52 Week Low | $1.17 | $2.83 |
| 52 Week High | $7.78 | $9.45 |
Technical Indicators
Market Signals| Indicator | TMCI | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 43.83 |
| Support Level | $3.84 | $3.01 |
| Resistance Level | $4.67 | $4.84 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 8.35 | 50.00 |
Price Performance
Historical ComparisonAbout TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.